Macchia, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 9.827
EU - Europa 8.029
AS - Asia 7.501
SA - Sud America 1.293
AF - Africa 236
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 15
Totale 26.916
Nazione #
US - Stati Uniti d'America 9.521
SG - Singapore 3.475
DE - Germania 2.961
CN - Cina 1.691
SE - Svezia 1.364
BR - Brasile 1.071
IT - Italia 783
VN - Vietnam 720
FR - Francia 653
UA - Ucraina 567
GB - Regno Unito 375
IN - India 367
IE - Irlanda 327
FI - Finlandia 271
ID - Indonesia 213
JP - Giappone 198
PL - Polonia 193
CA - Canada 181
HK - Hong Kong 151
BD - Bangladesh 141
TR - Turchia 137
RU - Federazione Russa 129
AR - Argentina 79
NL - Olanda 75
IQ - Iraq 74
MX - Messico 62
BE - Belgio 54
CI - Costa d'Avorio 54
ZA - Sudafrica 50
CZ - Repubblica Ceca 44
AT - Austria 43
ES - Italia 41
SA - Arabia Saudita 35
EC - Ecuador 33
IR - Iran 33
PK - Pakistan 30
CO - Colombia 29
LT - Lituania 29
KR - Corea 28
EG - Egitto 27
MA - Marocco 27
KE - Kenya 25
UZ - Uzbekistan 23
AE - Emirati Arabi Uniti 22
PH - Filippine 22
VE - Venezuela 20
JO - Giordania 19
CL - Cile 18
JM - Giamaica 18
TN - Tunisia 15
PY - Paraguay 14
CH - Svizzera 13
NP - Nepal 13
RO - Romania 13
UY - Uruguay 12
EU - Europa 11
IL - Israele 11
AU - Australia 10
AL - Albania 9
AZ - Azerbaigian 9
BH - Bahrain 9
DZ - Algeria 9
GR - Grecia 9
HU - Ungheria 9
MY - Malesia 9
BG - Bulgaria 8
OM - Oman 8
PE - Perù 8
PT - Portogallo 8
RS - Serbia 8
SN - Senegal 8
BO - Bolivia 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
PS - Palestinian Territory 7
AM - Armenia 6
ET - Etiopia 6
LK - Sri Lanka 6
MT - Malta 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
KZ - Kazakistan 5
LB - Libano 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
HN - Honduras 4
NI - Nicaragua 4
PA - Panama 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MK - Macedonia 3
NO - Norvegia 3
AG - Antigua e Barbuda 2
AO - Angola 2
Totale 26.865
Città #
Singapore 1.917
Chandler 1.365
San Jose 984
Ashburn 947
Beijing 374
Dublin 323
Jacksonville 321
The Dalles 264
San Mateo 260
New York 246
Ho Chi Minh City 241
Los Angeles 237
Lauterbourg 216
Nanjing 201
Jakarta 194
Wilmington 183
Hanoi 177
Warsaw 169
Dearborn 165
Tokyo 162
Munich 159
Milan 153
Boston 143
Nürnberg 140
Hefei 132
Frankfurt am Main 130
Hong Kong 128
Rome 126
Bremen 123
Dallas 123
Woodbridge 116
Marseille 112
Helsinki 109
Hyderabad 107
Ann Arbor 106
São Paulo 106
Houston 91
Izmir 88
Lawrence 86
Cattolica 84
Princeton 79
Moscow 78
Fairfield 76
Nanchang 76
Santa Clara 65
Seattle 65
St Louis 65
Council Bluffs 58
Redwood City 57
Buffalo 56
Abidjan 54
Brussels 53
Chicago 53
Orem 52
Toronto 51
Boardman 43
London 42
Shanghai 42
Leawood 40
Zhengzhou 37
Düsseldorf 36
Guangzhou 36
University Park 36
Da Nang 35
Turku 35
Brooklyn 34
Kent 34
Montreal 34
Paris 34
Shenyang 34
Stockholm 33
Amsterdam 32
Augusta 32
Hebei 32
Kunming 32
Phoenixville 32
Atlanta 31
Tianjin 31
Changsha 29
Fremont 29
Lancaster 29
Nuremberg 29
Johannesburg 28
Lappeenranta 28
Pune 27
Cambridge 26
Jiaxing 26
Rio de Janeiro 26
Falls Church 25
Mountain View 25
Seoul 25
Baghdad 24
Denver 24
Haiphong 24
Mumbai 24
Phoenix 24
Detroit 23
Nairobi 23
Norwalk 23
San Francisco 23
Totale 13.617
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 866
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 299
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 231
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 230
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 227
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 220
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 219
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 217
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 212
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 195
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 195
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 193
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 193
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 192
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 191
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 191
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 190
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 190
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 189
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 188
In Vivo Portal Dosimetry by an Ionization Chamber 188
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 187
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 186
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 186
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 185
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 183
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 182
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 180
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 177
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 175
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 175
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 175
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 174
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 174
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 172
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 171
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 171
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 171
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 170
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 170
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 170
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 167
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 165
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 165
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 165
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 165
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 164
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 164
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 162
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 162
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 160
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 158
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 158
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 158
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 157
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 157
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 157
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 155
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 155
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 155
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 154
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 153
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 153
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 153
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 152
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 151
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 150
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 150
Real time transit dosimetry for the breath-hold radiotherapy technique experience 148
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 144
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 142
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 142
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 141
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 141
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 141
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 140
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 140
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 140
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 140
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 140
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 140
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 139
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 139
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 139
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy 138
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 137
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 137
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 137
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 137
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 135
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 134
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 132
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 132
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 130
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis 130
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 129
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 128
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer 127
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 127
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 127
Totale 17.188
Categoria #
all - tutte 107.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.580 153 107 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20253.772 106 84 240 136 419 103 97 175 600 446 729 637
2025/202610.097 1.417 296 552 962 1.702 580 1.715 619 766 775 387 326
2026/2027114 114 0 0 0 0 0 0 0 0 0 0 0
Totale 27.714